| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/04/2006 | CN1839890A Method for preparing water-soluble bee glue product and use thereof |
| 10/04/2006 | CN1839888A Spider venom injection and its preparation method |
| 10/04/2006 | CN1839887A Spider freeze-drying powder preparation method and its uses in medicine and health product |
| 10/04/2006 | CN1839873A Pharmaceutically active uridine esters |
| 10/04/2006 | CN1839870A Use of geniposide as glicetin 1 acceptor excitomotor |
| 10/04/2006 | CN1839860A Ginsenoside F1 medicinal uses |
| 10/04/2006 | CN1839855A Ginsenoside F1 medicinal uses |
| 10/04/2006 | CN1839850A Dispersion tablet medicine containing oryzanol and its preparation method |
| 10/04/2006 | CN1839839A Preparation method of ziprasidone or its salt inclusion |
| 10/04/2006 | CN1839820A Antidepressant composition containing citalopram and cyclodextrin |
| 10/04/2006 | CN1839819A Medicinal composition containing tanshinone and its preparation process and usage |
| 10/04/2006 | CN1839799A Agglutinin-modified drug delivery system from nose to brain |
| 10/04/2006 | CN1839796A Tape preparation |
| 10/04/2006 | CN1277828C Piperzine derivative |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277823C Novel benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 10/04/2006 | CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 10/04/2006 | CN1277809C Benzal indone and benzyl indone derivative(s), and its preparing method and use |
| 10/04/2006 | CN1277567C Medicinal composition for treating nervous system disease and its preparation method |
| 10/04/2006 | CN1277544C Composite analgesic composition and its use |
| 10/04/2006 | CN1277543C Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 10/04/2006 | CN1277535C Ibuprofen active agent preparation |
| 10/04/2006 | CN1277532C Pearl powder soft capsule |
| 10/03/2006 | US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria |
| 10/03/2006 | US7115777 For therapy of hypertension, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty |
| 10/03/2006 | US7115766 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115720 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115662 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |
| 10/03/2006 | US7115645 Central nervous system disorders; antiinflammatory agents |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115633 Benzosuberonylpiperdine compounds as analgesics |
| 10/03/2006 | US7115631 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115616 Pyrimidinone compounds |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115599 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115565 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | US7115380 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115260 Interleukin-1β converting enzyme like apoptotic protease-6 |
| 10/03/2006 | US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation |
| 10/03/2006 | US7115256 Methods of treating schizophrenia |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery |
| 10/03/2006 | CA2426492C A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2261259C Alpha-amino acid amides, preparation thereof and the therapeutical use thereof |
| 10/03/2006 | CA2249654C Benzoxazines for enhancing synaptic response |
| 10/03/2006 | CA2215319C Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 10/03/2006 | CA2212440C Pharmaceutical preparations for tnf inhibition |
| 10/03/2006 | CA2151507C Pharmaceutical composition containing bicyclic type compounds |
| 09/28/2006 | WO2006102195A1 3-pyridinecarboxamide reduces nerve degeneration |
| 09/28/2006 | WO2006102194A1 Imidazopyridazine compounds |
| 09/28/2006 | WO2006102079A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | WO2006101903A1 Dipyrazoles as central nervous system agents |
| 09/28/2006 | WO2006101860A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 09/28/2006 | WO2006101808A1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 09/28/2006 | WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors |
| 09/28/2006 | WO2006101434A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS |
| 09/28/2006 | WO2006101422A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative |
| 09/28/2006 | WO2006101000A1 Anti-dermatan sulfate antibody and functional sulfated oligosaccharide |
| 09/28/2006 | WO2006100519A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 09/28/2006 | WO2006100088A1 Neural stem cells |
| 09/28/2006 | WO2006100080A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | WO2006100026A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists |
| 09/28/2006 | WO2006099972A1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| 09/28/2006 | WO2006099968A1 Metabolites for nk-i antagonists for emesis |
| 09/28/2006 | WO2006099783A1 A pharmaceutical composition for treating depression and method for preparation thereof |
| 09/28/2006 | WO2006099739A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | WO2006072608A3 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 09/28/2006 | WO2006068485A3 Temporally meal menu for infants |
| 09/28/2006 | WO2006058236A3 Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/28/2006 | US20060217424 Compounds for the inhibition of nitric oxide synthase |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217415 modulators of nicotinic and/or of the monoamine receptors such as 3-(Dibenzofuran-2-yloxy)-1-azabicyclo[2.2.2]octane, useful for the treatment of nervous system disorders, neurodegenerative diseases and drug abuse and dependence |
| 09/28/2006 | US20060217409 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
| 09/28/2006 | US20060217404 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases |
| 09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
| 09/28/2006 | US20060217395 Combinations of paroxetine and 4- (s) - (4-acetyl-piperazin-1-yl) -2- (r)- (4-fluoro-2-methyl- phenyl -piperidine-1-carboxylic acid [1- (r) (3,5-bis-trifluoromethyl-phenyl) -ethyl] methylamide for treatment of depression and / or anxiety |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217384 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217368 Drug for nerve regeneration |